Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope
Clinical Study of Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope
1 other identifier
interventional
20
1 country
1
Brief Summary
Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The fact that pharmacological therapy of AF is at best 50% effective has led to a search for surgical approaches over the last 20 years. Maze procedure was a classic method to treat AF. However, it is such a complex procedure that very few surgeons have adopted it. A few minimally invasive procedures to create transmural lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is catheter-based radiofrequency ablation, another one is video assisted epicardial radiofrequency ablation through small thoracic incisions in operating room. Recently, we invented an epicardial radiofrequency ablation method under totally thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Oct 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 14, 2009
CompletedFirst Posted
Study publicly available on registry
February 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFebruary 16, 2009
January 1, 2009
2.2 years
January 14, 2009
February 12, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Electrocardiography
2 years
Study Arms (1)
ablation
OTHERpatients with atrial fibrillation underwent radiofrequency ablation with totally thoracoscope.
Interventions
epicardial radiofrequency ablation to treat atrial fibrillation under totally thoracoscope
Eligibility Criteria
You may qualify if:
- Any patients with atrial fibrillation
You may not qualify if:
- Patients with hemostasis defects
- patients can not endure general anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Sites (1)
Institute of Cardiovascular Surgery, Xijing Hospital
Xi'an, Shannxi, 710032, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dinghua Yi, MD
Xijing Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 14, 2009
First Posted
February 16, 2009
Study Start
October 1, 2008
Primary Completion
December 1, 2010
Study Completion
June 1, 2011
Last Updated
February 16, 2009
Record last verified: 2009-01